SavedAdd your journal

Journals / E Journal of Cardiovascular Medicine / 2020 / Cilt: 8 - Sayı: 4

Delayed Coronary Occlusion After Transcatheter Aortic Valve Replacement in an Elderly Patient with Atrial Fibrillation

Sara ÇETİN ŞANLIALP
Özer ESER
Musa ŞANLIALP
Pages
206–210
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this case, we aimed to present the late coronary artery occlusion due to thrombus after TAVR and to emphasize the uncertainties and complexities in antithrombotic treatment in patients with TAVR, which may lead to catastrophic outcomes, especially in patients with atrial fibrillation

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Transcatheter aortic valve replacement (TAVR) is an effective procedure in selected patients with symptomatic severe aortic stenosis.
📊
Key Findings & Data:However, the complications associated with TAVR are still an important problem today.
💡
Conclusion & Impact:In this case, we aimed to present the late coronary artery occlusion due to thrombus after TAVR and to emphasize the uncertainties and complexities in antithrombotic treatment in patients with TAVR, which may lead to catastrophic outcomes, especially in patients with atrial fibrillation
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Transcatheter aortic valve replacement (TAVR) is an effective procedure in selected patients with symptomatic severe aortic stenosis. However, the complications associated with TAVR are still an important problem today. One of the life-threatening complications associated with TAVR is coronary occlusion, which requires immediate diagnosis and intervention. This serious complication also leads to poor prognosis and mortality. In this case, we aimed to present the late coronary artery occlusion due to thrombus after TAVR and to emphasize the uncertainties and complexities in antithrombotic treatment in patients with TAVR, which may lead to catastrophic outcomes, especially in patients with atrial fibrillation

🔖

Cite This Article

ŞANLIALP, S. Ç., ESER, Ö., ŞANLIALP, M. (2020). Delayed Coronary Occlusion After Transcatheter Aortic Valve Replacement in an Elderly Patient with Atrial Fibrillation. E Journal of Cardiovascular Medicine, Cilt: 8 - Sayı: 4, 206–210. https://ajindex.com/articles/193099

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Siqueira D, Abizaid A, Arrais M, Sousa JE. Transcatheter aortic valve replacement in elderly patients. J Geriatr Cardiol 2012;9:78-82
  2. Mark PR, Peter K, McFadyen JD. Thromboembolic and bleeding complications in transcatheter aortic valve implantation: insights on mechanisms, prophylaxis and therapy. J Clin Med 2019;25:8:280
  3. Jabbour RJ, Tanaka A, Colombo A, Latib A. Delayed coronary occlusion after transcatheter aortic valve ımplantation: ımplications for new transcatheter heart valve design and patient management. Interv Cardiol 2018;13:137-9
  4. Kennon S. Delayed coronary obstruction after transcatheter aortic valve ımplantation is not the structural equivalent of late stent thrombosis after percutaneous coronary ıntervention. Interv Cardiol 2018;13:60-1
  5. Carnicelli AP, De Caterina R, Halperin JL, et al. ENGAGE AF-TIMI 48 Investigators. Edoxaban for the prevention of thromboembolism in patients with atrial fibrillation and bioprosthetic valves. Circulation 2017;135:1273- 5
  6. Webb JG, Chandavimol M, Thompson CR, et al. Percutaneous aortic valve implantation retrograde from the femoral artery.Circulation 2006;113:842- 50
  7. Ramirez R, Ovakimyan O, Lasam G, Lafferty K. A very late presentation of a right coronary artery occlusion after transcatheter aortic valve replacement. Cardiol Res 2017;8:131-3
  8. Yalta K, Zorkun C, Yilmaztepe M, Gurlertop Y. Late coronary ischemic syndromes associated with transcatheter aortic valve implantation: A review of mechanistic and cilinical aspects. Indian Heart J 2018;70:901-6
  9. Paradis JM, Fried J, Nazif T, et al. Aortic stenosis and coronary artery disease: What do we know? What don’t we know? A comprehensive review of the literature with proposed treatment algorithms. Eur Heart J 2014;35:2069-82
  10. Valvo R, Costa G, Tamburino C, Barbanti M. Antithrombotic theraphy in transcatheter aortic valve replacement. Front. Cardiovasc. Med 2019;6:73.